A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
about
The HELLP syndrome: clinical issues and management. A ReviewLiver diseases in pregnancy: diseases unique to pregnancyFetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and managementAcute liver failure including acetaminophen overdoseAcute fatty liver of pregnancyCombined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial diseaseMechanisms of intrahepatic triglyceride accumulationAdvances in understanding and treating liver diseases during pregnancy: A reviewMetabolic disease in the fetus predisposes to maternal hepatic complications of pregnancyGeneral mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnoverAcute fatty liver of pregnancy after aspirin intakeLong-chain L-3-hydroxyacyl-coenzyme a dehydrogenase deficiency: a molecular and biochemical reviewMutations in long-chain 3-hydroxyacyl coenzyme a dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin depositionMedium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that resLack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden deathCarnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 Null (OCTN2(-/-)) MiceMitochondrial Trifunctional Protein Defects: Clinical Implications and Therapeutic ApproachesThrombocytopenic disorders in critically ill patients.Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts.Acute subdural haemorrhage in the postpartum period as a rare manifestation of possible HELLP (haemolysis, elevated liver enzymes, and low-platelet count) syndrome: a case report.Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genesPregnancy-related liver disorders.Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation.Metabolic cardiomyopathies.Detection of inborn errors of metabolism in the newborn.Fatty acid oxidation changes and the correlation with oxidative stress in different preeclampsia-like mouse models.Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase.Mechanisms of liver injury relevant to pediatric hepatology.Absence of the G1528C (E474Q) mutation in the alpha-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy.Genetic determinants of hepatic steatosis in man.Prospective study of liver dysfunction in pregnancy in Southwest WalesHigh-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies.Antiretroviral treatment of maternal HIV infectionGestational Diabetes Associated with a Novel Mutation (378-379insTT) in the Glycerol Kinase Gene.Acute liver failure in adults: an evidence-based management protocol for cliniciansAcute Fatty Liver of Pregnancy and its Differentiation from Other Liver Diseases in PregnancyInherited metabolic diseases and pregnancy.The mutations associated with dilated cardiomyopathy
P2860
Q21261342-6A9C8C67-E935-4B76-AFED-82CDD9C12F6FQ24596588-54AA27C5-4967-4103-8AC3-CA9C4CA45465Q24616340-E958B802-6E3A-478C-81CC-53BE7F18B22CQ24647134-A308E035-5B70-48A2-96C7-4565E76A4D3BQ24649161-8B1ABA42-2B44-489F-BED4-94B02990A8A5Q26770152-52B3FD01-8F05-4058-BE6B-41283456A517Q26773198-CD338815-8632-452D-8861-2D3522079628Q28080792-AFA3E644-F8C3-47FC-966E-440BD8CF8689Q28142066-1C62D110-DB5D-4C41-98E1-E1F806A9516EQ28186172-2579E5C0-6A76-495C-995F-C2E9E944A069Q28213008-E0054171-5185-4922-BFE8-8C186B67CBE3Q28214659-2EC75D0C-7470-46A2-A6FB-38BFA30DFA0FQ28269874-D0735869-BDEA-4C38-98CA-19B6186B95FAQ28364785-79004386-00EA-496C-B2B5-57B1E616A87BQ28505245-F0F0D547-BBAC-4599-9674-B21080AA0BC8Q28507159-B5128F22-E296-44EB-872C-92038F89C859Q28972544-649A2CD6-F9B2-46D2-A404-AE5EE5B37E64Q33333476-9B41063C-0E3E-4B1B-A5EF-DB56AFF54A35Q33412682-267C4209-23A0-46F9-BFE4-F07FCB781EE7Q33416148-0DF9F4DD-B120-4533-8A69-B4171D3FFAB0Q33617698-993C04D8-5CC3-4C05-A250-324542FB85A1Q33617715-996741AF-3BF3-4F66-97A4-44F6C3976CD7Q33731942-BDCAD031-C1B5-4B3F-83E7-8C4A3C18E147Q33978151-3CD7AE68-983D-402D-9B4A-EB6E0BB5FB47Q34141683-D1B9351A-CCA6-4815-91E8-3552D54EE039Q34216280-05AC9988-151E-4549-A3A2-0842017A82D7Q34229883-AB6CEF54-7A79-4763-862E-C83F8B1CA9C2Q34323290-6371C68E-6F6C-4934-81D5-350F628BF7CCQ34329661-B5FA9869-3CAF-46BA-A877-B5E8642B9B5BQ34559789-AD500256-B60C-489D-8039-2223881D51E1Q34616173-CCEB2954-88CA-4C2B-B852-F61118369098Q34646183-0B741C05-83A9-4AC4-A821-CA108182FD5FQ35595174-A8E50E6C-4178-4019-9B04-3FF01B1AB75CQ35698488-CD352928-ED84-4E84-889B-B4E2CF9137D0Q35826189-CF1DE838-C2F2-4F3A-86CC-160A497383A3Q35984671-328152AA-81C8-4BF7-A74C-7E59AAFC9C5CQ36002196-BD28A7AE-42FE-4E1E-A322-F3BE61BDA7B4Q36010607-38B6CCC2-CF99-4649-901F-D15DC12E8BCFQ36016747-C9EB7DF9-5AFB-4026-8564-71EF9EE958B1Q36102159-CA7D3E99-433E-463F-8A82-408D618C9594
P2860
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@ast
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@en
type
label
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@ast
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@en
prefLabel
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@ast
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@en
P2093
P1476
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
@en
P2093
Bennett MJ
Strauss AW
P304
P356
10.1056/NEJM199906033402204
P407
P577
1999-06-01T00:00:00Z